The efficacy of blood transfusions to improve microcirculatory oxygen delivery in anemic patients.

The efficacy of blood transfusions to improve microcirculatory oxygen delivery in anemic patients. - The efficacy of blood transfusions in anemic patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30782

Enrollment

Registered

2007-07-16

Start date

2007-01-22

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bloed doorstroming in de microcirculatie acute myeloid leukemia. leukemia

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Anemic patients and patients who under chemotherapy treatment receiving blood transfusion 2. Approval from the physician that will be treating the patients 3. Informed consent from each participating patient 4. Patients older than 18 years 5. Transfusion of blood from different storage age (more than 1 week difference in the duration of storage) 6. Transfusion of blood from storage age less than 1 week and more than 4 weeks.

Exclusion criteria

Exclusion criteria: 1. Patients that did not sign an informed consent 2. Patients younger than 18 years

Design outcomes

Primary

Measure	Time frame
Noninvasive measurements: Sidestream Dark-Field (SDF) Imaging-microcirculation quantification Fibre spectrophotometry and laser Doppler flowmetry (O2C) Invasive measurements: Blood sample	—

Secondary

Measure	Time frame
N.v.t.	—

Countries

Netherlands

Outcome results